India to Ecuador Pharmaceutical Export (2026) — $221.7M, 205 Suppliers | TransData Nexus

India to Ecuador Pharmaceutical Export (2026) — $221.7M, 205 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Ecuador

#	Formulation	Value	Share
1	Propofol Injectable Emulsion USP 2% (20m	$22.5M	10.2%
2	Amsulona Duo Hard Capsules (tamsulosin H	$15.9M	7.2%
3	Carvedilol Tablets 12.5mg Batch No.emv22	$15.3M	6.9%
4	Amoxicillin Oral Suspension BP 250mg/5ml	$9.0M	4.1%
5	Propofol Injectable Emulsion USP 1% (10m	$8.0M	3.6%
6	Pharmaceutical Finished Product Urea Cre	$5.4M	2.4%
7	Urea Cream 10% W/w Batch No.22103,22104	$5.2M	2.3%
8	Omeprazole Delayed - Release Capsules Us	$4.6M	2.1%
9	Cephalexin Capsules BP 500mg	$4.2M	1.9%
10	Tranexamic Acid Injection BP 500mg/5ml	$3.9M	1.7%
11	Cefadroxil Capsules USP 500mg-cetralon	$3.7M	1.7%
12	Nitrofurantoin Oral Suspension BP 25mg/5	$3.6M	1.6%
13	Clarithromycin Tablets USP 500mg	$3.5M	1.6%
14	Ibuprofen Tablets BP 800mg	$3.5M	1.6%
15	Pharmaceutical Finished Product Piperaci	$3.3M	1.5%

India exports 20+ pharmaceutical formulations to Ecuador with a combined trade value of $221.7M. Key products include Carvedilol ($15.3M), Amoxicillin ($9.0M), Omeprazole ($4.6M), Cephalexin ($4.2M), Nitrofurantoin ($3.6M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 3,504 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Ecuador Trade Routes

1Carvedilol$15.3M

2Amoxicillin$9.0M

3Omeprazole$4.6M

4Cephalexin$4.2M 5Nitrofurantoin$3.6M

Top Indian Exporters to Ecuador

1Wexford Laboratories Private Limited

$67.1M

2Caplin Point Laboratories Limited

$42.9M

3Caritas Healthcare Private Limited

$34.5M

4The Madras Pharmaceutical

$22.8M

Port Analysis — India to Ecuador Pharmaceutical Shipments

Indian Export Ports

CHENNAI AIR2.0%

KAMARAJAR PORT2.7%

AHEMDABAD ICD4.6%

SAHAR AIR6.6%

SAHAR AIR CARGO ACC (INBOM4)12.2%

Ecuador Import Ports

Guayaquil26.4%

QUITO29.2%

GUAYAQUIL38.8%

Quito0.1%

CUENCA0.1%

Trade Statistics

Total Value$221.7M

Shipments3,504

Indian Exporters205

Ecuador Buyers303

Avg Shipment$63K

Products2,433

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Ecuador Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Ecuador has experienced significant growth from 2022 to 2026. In 2022, the total export value was $221.7 million USD, with 3,504 shipments from 205 Indian exporters to 303 Ecuadorian buyers. The average shipment value stood at $63,000 USD. This upward trajectory underscores the strengthening bilateral trade relations and India's expanding footprint in Ecuador's pharmaceutical market.

2India's Market Position

India's pharmaceutical exports to Ecuador have been substantial, with a total export value of $294.7 million USD in 2024. This positions India as a significant supplier in Ecuador's pharmaceutical import landscape, reflecting the strategic importance of this trade corridor.

3Recent Developments

In January 2025, Ecuador's National Agency for Regulation, Control, and Sanitary Surveillance (ARCSA) implemented new sanitary technical regulations for medicines, effective June 30, 2025. This regulation mandates that all pharmaceuticals intended for human use obtain and maintain a sanitary registration certificate to be legally manufactured, imported, or sold in Ecuador. This development is crucial for Indian pharmaceutical exporters, as it necessitates compliance with updated registration processes to continue market access.

Ecuador Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to export to Ecuador must navigate a comprehensive registration process overseen by ARCSA. This process includes submitting a detailed dossier, which must adhere to the Common Technical Document (CTD) format, a globally recognized standard for pharmaceutical product submissions. The dossier should encompass all necessary documentation, including clinical and non-clinical data, manufacturing details, and labeling information. Additionally, bioequivalence studies may be required to demonstrate therapeutic equivalence to the reference product. The registration timeline can vary, but it is essential for exporters to initiate the process well in advance to ensure timely market entry.

2GMP & Facility Requirements

Ecuador requires that manufacturing facilities comply with Good Manufacturing Practices (GMP) standards to ensure the quality and safety of pharmaceutical products. The inspection process involves a thorough evaluation of the manufacturing site, including facility conditions, equipment, personnel qualifications, and adherence to GMP guidelines. Ecuador recognizes GMP certifications from reputable international bodies, facilitating mutual recognition agreements that streamline the approval process for foreign manufacturers.

3Import Documentation

To import pharmaceutical products into Ecuador, exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Issued by the regulatory authority in the exporting country, confirming the product's compliance with national regulations.

Certificate of Analysis (CoA): Demonstrates that the product meets specified quality standards.

GMP Certificate: Verifies that the manufacturing facility adheres to GMP standards.

Additionally, importers must register with the National Customs Service of Ecuador (SENAE) and comply with the ECUAPASS customs system. Collaboration with authorized customs agents is essential for the clearance of pharmaceutical shipments.

TransData Nexus Research · Ecuador regulatory databasesMar 2026

FAQ — India to Ecuador Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Ecuador?

India exported pharmaceuticals worth $221.7M to Ecuador across 3,504 verified shipments.

Who are the top Indian pharmaceutical exporters to Ecuador?

1. WEXFORD LABORATORIES PRIVATE LIMITED — $67.1M. 2. CAPLIN POINT LABORATORIES LIMITED — $42.9M. 3. CARITAS HEALTHCARE PRIVATE LIMITED — $34.5M. Total: 205 suppliers.

Which companies in Ecuador import pharmaceuticals from India?

1. DYVENPRO DISTRIBUCION Y VENTA DE — $67.3M. 2. NEOETHICALS CIA LTDA — $42.7M. 3. TO THE PURCHASE MANAGER — $28.3M. 303 buyers total.

What pharmaceutical products does India export most to Ecuador?

1. Propofol Injectable Emulsion USP 2% (20m ($22.5M, 10.2%); 2. Amsulona Duo Hard Capsules (tamsulosin H ($15.9M, 7.2%); 3. Carvedilol Tablets 12.5mg Batch No.emv22 ($15.3M, 6.9%); 4. Amoxicillin Oral Suspension BP 250mg/5ml ($9.0M, 4.1%); 5. Propofol Injectable Emulsion USP 1% (10m ($8.0M, 3.6%)

Which ports handle pharmaceutical shipments from India to Ecuador?

Export: CHENNAI AIR, KAMARAJAR PORT, AHEMDABAD ICD, SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4). Import: Guayaquil, QUITO, GUAYAQUIL, Quito, CUENCA.

Why does Ecuador import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $221.7M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Ecuador?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Ecuador pharmaceutical trade?

$63.3K per consignment across 3,504 shipments.

How many Indian pharmaceutical companies export to Ecuador?

205 Indian companies. Largest: WEXFORD LABORATORIES PRIVATE LIMITED with $67.1M.

How can I find verified Indian pharmaceutical suppliers for Ecuador?

TransData Nexus covers 205 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Ecuador identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 3,504 verified shipments from 205 Indian exporters to 303 Ecuador buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

205 Exporters

303 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Ecuador Pharmaceutical Export

Top Pharmaceutical Formulations — India to Ecuador

Top Pharmaceutical Products — India to Ecuador Trade Routes

Top Indian Exporters to Ecuador

Port Analysis — India to Ecuador Pharmaceutical Shipments

Indian Export Ports

Ecuador Import Ports

Trade Statistics

Other Destinations

India–Ecuador Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Ecuador Buyers from India

Product Routes

Full Dataset Access

Ecuador Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Ecuador

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Ecuador

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Ecuador Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Ecuador for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Ecuador

1Competing Origins

2India's Competitive Edge

3Challenges & Threats